Document is current
Any future updates will be listed below
-
Authors
Rose, Maddison
Burgess, Joshua T.
Cheong, Chee Man
Richard, Iain
Suraweera, Amila
Adams, Mark N.
Duijf, Pascal H. G.
O’Byrne, Kenneth J.
Richard, Derek J.
Bolderson, Emma
-
Funding
Funding for this research was provided by:
QUT Centre for Genomics and Personalised Health
Tour de Cure
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 3 July 2025
First Online: 15 July 2025
Declarations
:
: The authors declare competing financial interests; EB, DR and KO are founders of Carpe Vitae Pharmaceuticals. EB, JB, MA, KO, DR are inventors on provisional patent applications filed by Queensland University of Technology. The remaining authors do not have any competing interest.
: Experimental procedures were approved by the Queensland University of Technology, Human. 212 Research Ethics Committee (approval numbers 1700000940 and 1900000269).
